No products in the cart.

Anti-SNX1 antibody

SKU Product Brand Unit Availability Price Quantity  
AB-06-4139
Anti-SNX1 antibody
Erpan Tech In stock

Specifications        

Product cat: AB-06-4139
Product type: Primary antibody
Antigen: SNX1
Immunogen: Recombinant protein within human SNX1 aa 50-250.
Species immunized: Rabbit
Isotype: IgG
Applications: Western Blot (1:900-1:2400); Immunohistochemistry (1:90-1:260); Immunocytochemistry (1:100-1:250); Flow Cytometry (1:70-1:260); Immunofluorescence
Reactivity: Mouse, Rat and Human
Clonality (clone number): Monoclonal (JG40-06)
Form: Liquid
Buffer: Tris-HCl buffer (pH7.4), 1% BSA, 40% glycerol, 0.05% NaN3.
Concentration: 1 mg/ml
Purity: Protein A affinity purified
Storage: Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles.
Alternative names: HsT17379 antibody
MGC8664 antibody
SNX 1 antibody
SNX 1a antibody
Snx1 antibody
SNX1_HUMAN antibody
SNX1A antibody
Sorting nexin 1 antibody
Sorting nexin 1A antibody
Sorting nexin-1 antibody
Vps5 antibody
Show More

Target information

Involved in several stages of intracellular trafficking. Interacts with membranes containing phosphatidylinositol 3-phosphate (PtdIns(3P)) or phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P2) (PubMed:12198132). Acts in part as component of the retromer membrane-deforming SNX-BAR subcomplex. The SNX-BAR retromer mediates retrograde transport of cargo proteins from endosomes to the trans-Golgi network (TGN) and is involved in endosome-to-plasma membrane transport for cargo protein recycling. The SNX-BAR subcomplex functions to deform the donor membrane into a tubular profile called endosome-to-TGN transport carrier (ETC) (Probable). Can sense membrane curvature and has in vitro vesicle-to-membrane remodeling activity (PubMed:19816406, PubMed:23085988). Involved in retrograde endosome-to-TGN transport of lysosomal enzyme receptors (IGF2R, M6PR and SORT1) and Shiginella dysenteria toxin stxB. Plays a role in targeting ligand-activated EGFR to the lysosomes for degradation after endocytosis from the cell surface and release from the Golgi (PubMed:12198132, PubMed:15498486, PubMed:17550970, PubMed:17101778, PubMed:18088323, PubMed:21040701). Involvement in retromer-independent endocytic trafficking of P2RY1 and lysosomal degradation of protease-activated receptor-1/F2R (PubMed:16407403, PubMed:20070609). Promotes KALRN- and RHOG-dependent but retromer-independent membrane remodeling such as lamellipodium formation; the function is dependent on GEF activity of KALRN (PubMed:20604901). Required for endocytosis of DRD5 upon agonist stimulation but not for basal receptor trafficking (PubMed:23152498).

Provider

Erpantech Laboratory

download

Material-Safety-Data-Sheet.pdf (47991 downloads)